Product
Help
Pricing
About
Jobs
Log in
Get started
Author
Add to collection
James M. Maclean
Observed names:
J. Maclean,
James M Maclean,
James M. MacLean,
James Maclean,
Maclean, James
Institution:
Planet Biotechnology (United States)
Observed institutions:
Royal Marsden NHS Foundation Trust,
University of Cape Town,
Blood Cancer UK,
Planet Biotechnology (United States),
Royal Marsden Hospital,
Instituto Nacional de Câncer - INCA,
Institute of Infectious Disease and Molecular Medicine
show all 7
OpenAlex ID:
A5109357911
Optimization of human papillomavirus type 16 (HPV-16) L1 expression in plants: comparison of the suitability of different HPV-16 L1 gene variants and different cell-compartment localization
2007
·
J. Maclean
, M. Koekemoer
, et al.
·
Journal of General Virology
·
274
Expression of HIV-1 antigens in plants as potential subunit vaccines
2008
·
Ann Meyers
, Ereck Chakauya
, et al.
·
BMC Biotechnology
·
121
PDF
Monoclonal Origin of Concordant T-Cell Malignancy in Identical Twins
1997
·
Anthony M. Ford
, Maria S. Pombo-de-Oliveira
, et al.
·
Blood
·
102
Transient Co-Expression of Post-Transcriptional Gene Silencing Suppressors for Increased in Planta Expression of a Recombinant Anthrax Receptor Fusion Protein
2011
·
Lucas Arzola
, Junxing Chen
, et al.
·
International Journal of Molecular Sciences
·
47
PDF
Setting up a platform for plant-based influenza virus vaccine production in South Africa
2012
·
Elizabeth Mortimer
, James M Maclean
, et al.
·
BMC Biotechnology
·
46
PDF
Recombinant Anthrax Toxin Receptor-Fc Fusion Proteins Produced in Plants Protect Rabbits against Inhalational Anthrax
2010
·
Keith L. Wycoff
, Archana Belle
, et al.
·
Antimicrobial Agents and Chemotherapy
·
45
A prime–boost immunisation regimen using recombinant BCG and Pr55gag virus-like particle vaccines based on HIV type 1 subtype C successfully elicits Gag-specific responses in baboons
2009
·
Gerald K. Chege
, Robin Thomas
, et al.
·
Vaccine
·
42
A recombinant human papillomavirus (HPV) type 16 L1–vaccinia virus murine challenge model demonstrates cell-mediated immunity against HPV virus-like particles
1999
·
Dianne Marais
, Jo-Ann Passmore
, et al.
·
Journal of General Virology
·
34
Vaccination strategies for the prevention of cervical cancer
2005
·
James Maclean
, Edward P Rybicki
, et al.
·
Expert Review of Anticancer Therapy
·
21
Anti‐infective immunoadhesins from plants
2015
·
Keith Wycoff
, James Maclean
, et al.
·
Plant Biotechnology Journal
·
19
PDF
An optimized Factor H-Fc fusion protein against multidrug-resistant Neisseria gonorrhoeae
2022
·
Jutamas Shaughnessy
, Aleyo Chabeda
, et al.
·
Frontiers in Immunology
·
16
PDF
Equilibrium and Kinetics of Sin Nombre Hantavirus Binding at DAF/CD55 Functionalized Bead Surfaces
2014
·
Tione Buranda
, Scarlett Swanson
, et al.
·
Viruses
·
15
PDF
CD97 is associated with mitogenic pathway activation, metabolic reprogramming, and immune microenvironment changes in glioblastoma
2022
·
Michael M. Safaee
, Elaina J. Wang
, et al.
·
Scientific Reports
·
14
PDF
Development of Complement Factor H–Based Immunotherapeutic Molecules in Tobacco Plants Against Multidrug-Resistant Neisseria gonorrhoeae
2020
·
Jutamas Shaughnessy
, Y Tran
, et al.
·
Frontiers in Immunology
·
14
Correction: Buranda, T. et al. Equilibrium and Kinetics of Sin Nombre Hantavirus Binding at DAF/CD55 Functionalized Bead Surfaces. Viruses 2014, 6, 1091-1111
2014
·
Tione Buranda
, Scarlett Swanson
, et al.
·
Viruses
PDF
Investigation of the use of recombinant BCG, expressing the major capsid protein (LI) of human papillomavirus type 16, as a candidate vaccine for cervical cancer
2005
·
James Maclean
·
Open University of Cape Town (University of Cape Town)
Show more works
View as search
Works count:
17
Citation count:
810
H-index:
14
I10-index:
14
Year
Topic
Type